Timing of caffeine therapy in very low birth weight infants

Journal of Pediatrics

Volumn 164, Issue 5, 2014, Pages 957-958

  Schmidt, Barbara ^a   Davis, Peter G ^b   Roberts, Robin S ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

BPD; Bronchopulmonary dysplasia; Caffeine for Apnea of Prematurity; CAP; Very low birth weight; VLBW

Indexed keywords

BRONCHOPULMONARY DYSPLASIA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; INFANT MORTALITY; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; MALE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84898793876     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.01.054     Document Type: Editorial

References (14)

1. J.A. Kuzemko, and J. Paala Apnoeic attacks in the newborn treated with aminophylline Arch Dis Child 48 1973 404 406
2. J.V. Aranda, W. Gorman, H. Bergsteinsson, and T. Gunn Efficacy of caffeine in treatment of apnea in the low-birth-weight infant J Pediatr 90 1977 467 472
3. B. Schmidt Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway? J Pediatr 135 1999 526 528
4. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, and A. Ohlsson et al. Caffeine therapy for apnea of prematurity N Engl J Med 354 2006 2112 2121
5. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, and A. Ohlsson et al. Long-term effects of caffeine therapy for apnea of prematurity N Engl J Med 357 2007 1893 1902
6. B. Schmidt, P.J. Anderson, L.W. Doyle, D. Dewey, R.E. Grunau, and E.V. Asztalos et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity JAMA 307 2012 275 282
7. D. Dukhovny, S.A. Lorch, B. Schmidt, L.W. Doyle, J.H. Kok, and R.S. Roberts et al. Economic evaluation of caffeine for apnea of prematurity Pediatrics 127 2011 e146 e155
8. Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK Jr, Smith PB, et al. Medication use in the neonatal intensive care unit. Am J Perinatol, in press.
9. P.G. Davis, B. Schmidt, R.S. Roberts, L.W. Doyle, E. Asztalos, and R. Haslam et al. Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups J Pediatr 156 2010 382 387
10. N.R. Dobson, R.M. Patel, B. Smith, D.R. Kuehn, J. Clark, and S. Vyas-Read et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants J Pediatr 164 2014 992 998
11. ClinicalTrials.gov. Miami: Caffeine to reduce mechanical ventilation in preterm infants. http://clinicaltrials.gov/show/NCT01751724. Accessed February 3, 2014.
12. M.M. Laughon, J.C. Langer, C.L. Bose, P.B. Smith, N. Ambalavanan, and K.A. Kennedy et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants Am J Respir Crit Care Med 183 2011 1715 1722
13. L.W. Doyle, J. Cheong, R.W. Hunt, K.J. Lee, D.K. Thompson, and P.G. Davis et al. Caffeine and brain development in very preterm infants Ann Neurol 68 2010 734 742
14. S.A. Rivkees, and C.C. Wendler Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection Pediatr Res 69 2011 271 278